SCOTT D SANDELL
CIK 1237289 · last filed 2026-03-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$19.83B
Companies
79
Total Filings
312
Lifetime Open-Market Net
-$149.76M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KRRO | 10%+ Owner | 1,297,893 | $11.61 | $15.07M | $3.30M | 2 | 2026-03-12 |
| SGP | 10%+ Owner | 5,097,538 | $18.44 | $94.00M | $15.00M | 1 | 2026-02-11 |
| NeueHealth, Inc. (BHG) Delisted | Director | 674,830 | $16.35 | $11.03M | $34.97M | 8 | 2025-10-06 |
| NET | Director | 47,536 | $228.48 | $10.86M | -$139.03M | 25 | 2025-06-09 |
| COUR | Director | 2,277,853 | $5.34 | $12.16M | $0 | 11 | 2025-05-23 |
| SNTI | 10%+ Owner | 3,775,615 | $0.96 | $3.63M | $0 | 1 | 2025-03-12 |
| NeueHealth, Inc. (NEUE) Delisted | 10%+ Owner | — | $6.75 | — | $0 | 2 | 2024-10-03 |
| MBX | 10%+ Owner | 1,023,103 | $35.51 | $36.33M | $8.00M | 1 | 2024-09-17 |
| SGMT | 10%+ Owner | 3,000,275 | $6.48 | $19.44M | $0 | 1 | 2024-01-31 |
| SVRA | 10%+ Owner | 24,471,264 | $5.26 | $128.72M | $1000.0K | 1 | 2023-07-19 |
| MIRM | 10%+ Owner | 163 | $99.34 | $16.2K | $6.75M | 2 | 2023-06-15 |
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | 10%+ Owner | 2,237,196 | $15.70 | $35.12M | -$5.04M | 6 | 2023-01-27 |
| Arcellx, Inc. (ACLX) Delisted | 10%+ Owner | 6,746,494 | $115.07 | $776.32M | $39.98M | 3 | 2022-12-27 |
| Akouos, Inc. (AKUS) Delisted | 10%+ Owner | 0 | $13.29 | $0 | $10.00M | 2 | 2022-12-02 |
| IONQ.WS | 10%+ Owner | 1,141 | $46.23 | $52.7K | $0 | 1 | 2022-11-18 |
| AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | 10%+ Owner | 386 | $15.00 | $5.8K | $24.62M | 17 | 2022-10-21 |
| GENOCEA BIOSCIENCES, INC. (GNCA) Delisted | 10%+ Owner | 0 | $0.00 | $0 | $21.03M | 4 | 2022-05-26 |
| HOOD | Director | 0 | $93.19 | $0 | -$123.2K | 9 | 2022-05-16 |
| TRVI | 10%+ Owner | 10,421,428 | $14.21 | $148.09M | $31.80M | 4 | 2022-04-13 |
| IMRA | 10%+ Owner | 2,866,513 | $17.02 | $48.79M | -$6.01M | 1 | 2022-04-07 |
| BE | Director | 55,751 | $260.22 | $14.51M | $20.00M | 14 | 2022-04-01 |
| Casper Sleep Inc. (CSPR) Delisted | 10%+ Owner | 0 | $6.78 | $0 | $0 | 1 | 2022-01-26 |
| ARDX | 10%+ Owner | 47 | $5.69 | $267 | $80.74M | 13 | 2021-12-27 |
| Metacrine, Inc. (MTCR) Delisted | 10%+ Owner | 2,563,257 | $0.49 | $1.27M | $9.51M | 2 | 2021-12-27 |
| CVRX | 10%+ Owner | 1,800,583 | $5.03 | $9.06M | $9.01M | 1 | 2021-07-07 |
| GLUE | 10%+ Owner | 7,692,298 | $18.23 | $140.27M | $19.95M | 1 | 2021-06-30 |
| Desktop Metal, Inc. (DM) Delisted | 10%+ Owner | 5,544 | $4.96 | $27.5K | $0 | 1 | 2021-06-10 |
| Eargo, Inc. (EAR) Delisted | 10%+ Owner | 195 | $2.57 | $501 | $5.60M | 2 | 2021-05-26 |
| MRKR | 10%+ Owner | 10,714,285 | $1.38 | $14.79M | $10.00M | 1 | 2021-03-18 |
| Regulus Therapeutics Inc. (RGLS) Delisted | 10%+ Owner | 6,451,056 | $8.16 | $52.64M | $3.96M | 3 | 2020-12-07 |
| SPT | 10%+ Owner | 165,945 | $7.29 | $1.21M | $0 | 1 | 2020-11-17 |
| Mersana Therapeutics, Inc. (MRSN) Delisted | 10%+ Owner | 11,969,780 | $29.08 | $348.08M | $14.77M | 5 | 2020-09-16 |
| Inozyme Pharma, Inc. (INZY) Delisted | 10%+ Owner | 2,187,689 | $4.00 | $8.75M | $4.00M | 1 | 2020-07-28 |
| NKTX | 10%+ Owner | 2,235,449 | $2.86 | $6.39M | $12.00M | 1 | 2020-07-16 |
| SENS | 10%+ Owner | 19,867,361 | $7.18 | $142.65M | $27.21M | 5 | 2020-04-23 |
| Adaptimmune Therapeutics PLC (ADAP) Delisted | 10%+ Owner | 19,500,000 | $0.06 | $1.13M | $5.00M | 1 | 2020-01-28 |
| TESARO, Inc. (TSRO) Delisted | 10%+ Owner | 0 | — | — | $73.03M | 7 | 2019-01-22 |
| ESTC | 10%+ Owner | 655,522 | $60.35 | $39.56M | $0 | 1 | 2018-10-10 |
| ASND | 10%+ Owner | 82,978,668 | $218.06 | $18.09B | $49.02M | 4 | 2018-09-10 |
| Surface Oncology, Inc. (SURF) Delisted | 10%+ Owner | 3,179,544 | $1.07 | $3.40M | $2.00M | 1 | 2018-04-23 |
| Oruka Therapeutics, Inc. (ABIO) Delisted | 10%+ Owner | 0 | $28.80 | $0 | -$731.3K | 1 | 2018-02-27 |
| Cascadian Therapeutics, Inc. (CASC) Delisted | 10%+ Owner | 10,882,574 | — | — | $0 | 1 | 2018-02-22 |
| APPN | 10%+ Owner | 9,628 | $24.01 | $231.2K | -$66.07M | 4 | 2018-02-15 |
| SYBX | 10%+ Owner | 4,228,940 | $0.69 | $2.92M | $0 | 2 | 2018-01-26 |
| Care.com Inc (CRCM) Delisted | 10%+ Owner | 504 | — | — | $0 | 2 | 2017-11-08 |
| RYTM | 10%+ Owner | 4,359,956 | $88.38 | $385.33M | $9.35M | 1 | 2017-10-10 |
| MULESOFT, INC (MULE) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2017-03-22 |
| Zosano Pharma Corp (ZSAN) Delisted | 10%+ Owner | 952,809 | $0.56 | $531.3K | -$13.80M | 4 | 2017-02-14 |
| Achaogen, Inc. (AKAO) Delisted | 10%+ Owner | 5,215,128 | — | — | $6.75M | 1 | 2016-12-19 |
| Ra Pharmaceuticals, Inc. (RARX) Delisted | 10%+ Owner | 1,858,450 | — | — | $4.39M | 1 | 2016-10-31 |
| Roka BioScience, Inc. (ROKA) Delisted | 10%+ Owner | 3,216,810 | — | — | $4.60M | 3 | 2016-09-30 |
| TriVascular Technologies, Inc. (TRIV) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2016-02-04 |
| Epizyme, Inc. (EPZM) Delisted | 10%+ Owner | 5,854,351 | $1.47 | $8.61M | $23.87M | 4 | 2016-01-12 |
| SUPN | 10%+ Owner | 6,241,250 | $44.41 | $277.17M | $216.13M | 4 | 2015-11-12 |
| Avalo Therapeutics, Inc. (CERC.U) Delisted | 10%+ Owner | 594,245 | — | — | $0 | 1 | 2015-10-20 |
| SYNLOGIC, INC. (MIRN) Delisted | 10%+ Owner | 1,241,650 | — | — | $6.00M | 1 | 2015-10-06 |
| Vitae Pharmaceuticals, Inc (VTAE) Delisted | 10%+ Owner | 8,250 | — | — | $0 | 1 | 2015-07-02 |
| BOX | 10%+ Owner | 0 | $25.39 | $0 | $0 | 1 | 2015-01-29 |
| Tableau Software Inc (DATA) Delisted | Director | 55,705 | — | — | -$600.28M | 14 | 2014-12-08 |
| CVENT INC (CVT) Delisted | 10%+ Owner | 1,009 | $8.52 | $8.6K | -$46.31M | 5 | 2014-11-28 |
| DERM | 10%+ Owner | 3,433,810 | $6.34 | $21.77M | $1.11M | 1 | 2014-10-08 |
| Viracta Therapeutics, Inc. (SNSS) Delisted | 10%+ Owner | 4,817,733 | $18.62 | $89.71M | -$6.84M | 2 | 2014-08-29 |
| Loxo Oncology, Inc. (LOXO) Delisted | 10%+ Owner | 1,789,420 | — | — | $3.00M | 1 | 2014-08-06 |
| WDAY | Director | 9,490 | $130.80 | $1.24M | -$1.53M | 6 | 2014-03-04 |
| BOINGO WIRELESS, INC. (WIFI) Delisted | 10%+ Owner | 4,467,960 | $13.99 | $62.51M | -$27.4K | 2 | 2013-12-12 |
| FUSION-IO, INC. (FIO) Delisted | Director | 7,053,379 | — | — | -$44.65M | 19 | 2013-11-21 |
| AUDIENCE INC (ADNC) Delisted | 10%+ Owner | 1,016 | — | — | -$75.0K | 3 | 2013-11-06 |
| XOOM Corp (XOOM) Delisted | 10%+ Owner | 2,239,385 | — | — | $0 | 1 | 2013-10-31 |
| GRPN | 10%+ Owner | 0 | $17.01 | $0 | -$345.4K | 2 | 2013-09-17 |
| Clovis Oncology, Inc. (CLVS) Delisted | 10%+ Owner | 575 | $0.08 | $47 | $17.11M | 2 | 2013-06-05 |
| CHANNELADVISOR CORP (ECOM) Delisted | 10%+ Owner | 2,765,599 | $23.09 | $63.86M | $0 | 1 | 2013-05-29 |
| Millennial Media Inc. (MM) Delisted | 10%+ Owner | 8,196,614 | — | — | -$21.48M | 2 | 2012-10-30 |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | 10%+ Owner | 1,513,927 | — | — | $5.00M | 1 | 2012-08-02 |
| INNERWORKINGS INC (INWK) Delisted | 10%+ Owner | 4,529,190 | — | — | -$12.65M | 7 | 2012-03-30 |
| Echo Global Logistics, Inc. (ECHO) Delisted | 10%+ Owner | 901 | $48.24 | $43.5K | $0 | 1 | 2012-03-01 |
| VG | 10%+ Owner | 4,558,701 | $13.08 | $59.63M | $0 | 1 | 2011-03-15 |
| INHIBITEX, INC. (INHX) Delisted | 10%+ Owner | 6,898,294 | — | — | $3.00M | 1 | 2009-10-30 |
| Data Domain, Inc. (DDUP) Delisted | Director | 43,750 | — | — | -$27.33M | 12 | 2009-07-21 |
| TNDM | 10%+ Owner | 5,927,472 | $16.60 | $98.40M | $0 | 1 | 2007-11-09 |
Recent Filings · Page 4 of 32
312 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-04 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Sell (S) | −398,133 | -$1.19M | EDGAR |
| 2022-12-27 | Arcellx, Inc. (ACLX) Delisted | Sell (S) | −390 | -$12.4K | EDGAR |
| 2022-12-22 | Arcellx, Inc. (ACLX) Delisted | Mixed | −1,998,378 | -$5.5K | EDGAR |
| 2022-12-02 | Akouos, Inc. (AKUS) Delisted | U | −4,294,207 | $0 | EDGAR |
| 2022-11-18 | IONQ.WS | Other (J) | −11,681,334 | $0 | EDGAR |
| 2022-10-21 | AVEO PHARMACEUTICALS, INC. (AVEO) Delisted | Other (J) | −3,949,398 | $0 | EDGAR |
| 2022-10-19 | NeueHealth, Inc. (BHG) Delisted | Buy (P) | — | $0 | EDGAR |
| 2022-09-07 | COUR | Gift (G) | −37,484 | $0 | EDGAR |
| 2022-08-30 | COUR | — | — | $0 | EDGAR |
| 2022-06-23 | Arcellx, Inc. (ACLX) Delisted | Buy (P) | +2,500,000 | $40.00M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.